Chronic Renal Failure - MD Browse

Chronic Renal Failure

Speciality
Spotlight

Chronic
Renal Failure

P
Ruggenenti, for the “Gruppo Italiano di Studi
Epidemiologic in Nefrologia” (GISEN) (Mario
Negri Inst, Italy; Azienda Ospedaliera, Bergamo,
Italy) Urinary
Protein Excretion Rate Is the Best Independent
Predictor of ESRF in Non-diabetic
Proteinuric Chronic Nephropathies

Kidney
Int 53: 1209-1219, 1998



The
best independent predictor of disease progression
and end-stage renal failure in chronic nephropathies
is urinary protein excretion rate.



Several
factors have been implicated in the progression of
chronic renal disease.
These included proteinuria, hypertension,
black race, diagnosis of polycystic kidney disease,
serum transferrin levels, and serum high-density
lipoprotein cholesterol.

ES
Ginsburg, B Walsh, L Greenberg, et al [ Harvard Med
School, Boston ]

Effects of Estrogen Replacement Therapy on the
Lipoprotein Profile in Postmenopausal Women with
ESRD.

kidney Int 54 : 1344-1350, 1998

Standard dosages of estrogen increase HDL
cholesterol to a level expected to improve the
cardiovascular risk profile of postmenopausal women.
Further research is needed to determine whether
estrogen replacement reduces the incidences or
severity of cardiovascular disease in ESRD patients
to a degree considered normal

Speciality Spotlight

Chronic Renal Failure

P Ruggenenti, for the “Gruppo Italiano di Studi Epidemiologic in Nefrologia” (GISEN) (Mario Negri Inst, Italy; Azienda Ospedaliera, Bergamo, Italy) Urinary Protein Excretion Rate Is the Best Independent Predictor of ESRF in Non-diabetic Proteinuric Chronic Nephropathies
Kidney Int 53: 1209-1219, 1998

The best independent predictor of disease progression and end-stage renal failure in chronic nephropathies is urinary protein excretion rate.

Several factors have been implicated in the progression of chronic renal disease. These included proteinuria, hypertension, black race, diagnosis of polycystic kidney disease, serum transferrin levels, and serum high-density lipoprotein cholesterol.

ES Ginsburg, B Walsh, L Greenberg, et al [ Harvard Med School, Boston ]
Effects of Estrogen Replacement Therapy on the Lipoprotein Profile in Postmenopausal Women with ESRD.
kidney Int 54 : 1344-1350, 1998

Standard dosages of estrogen increase HDL cholesterol to a level expected to improve the cardiovascular risk profile of postmenopausal women. Further research is needed to determine whether estrogen replacement reduces the incidences or severity of cardiovascular disease in ESRD patients to a degree considered normal

By Oleg Iuchis|2022-07-20T16:41:28+00:00July 20, 2022|Uncategorized|Comments Off

About the Author: Oleg Iuchis

It is a long established fact that the read will been distracted by there readable an important content. It is a long established fact that the read will been distracted.

It is a long established fact that the read will been distracted by there readable an important content. It is a long established fact that the read will been distracted.